Science Explorer Back to mapMap
Discussion
Institution · Universities at Shady Grove

Most cited papers from Universities at Shady Grove

Universities at Shady Grove

What are the most cited papers from Universities at Shady Grove?

The most cited paper from Universities at Shady Grove is "mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases" (Giulietta Maruggi, Cuiling Zhang, Junwei Li et al., 2019), with 522 citations. Next come "Perceived Organizational Support: Reducing the Negative Influence of Coworker Withdrawal Behavior" (323) and "Asked More Often: Gender Differences in Faculty Workload in Research Universities and the Work Interactions That Shape Them" (291).

Showing 50 of 58 papers. Every paper with more than 11 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases Giulietta Maruggi, Cuiling Zhang, Junwei Li et al. · Molecular Therapy Open access 10 Feb 2019 522
2 Perceived Organizational Support: Reducing the Negative Influence of Coworker Withdrawal Behavior Paul Eder, Robert Eisenberger · Journal of Management 26 Oct 2007 323
3 Asked More Often: Gender Differences in Faculty Workload in Research Universities and the Work Interactions That Shape Them KerryAnn O’Meara, Alexandra Kuvaeva, Gudrun Nyunt et al. · American Educational Research Journal 21 Jul 2017 291
4 CRYSTAL STRUCTURE OF THE CYTOCHROME P450-CAM ACTIVE SITE MUTANT THR252ALA Reetta Raag, Susan A. Martinis, Stephen G. Sligar et al. · Biochemistry 4 Jun 1991 210
5 A global magnetic anomaly map Michael W. Regan, Joe Cain, William M. Davis · Journal of Geophysical Research Atmospheres 10 Feb 1975 178
6 Contribution of tyrosine 6 to the catalytic mechanism of isoenzyme 3-3 of glutathione S-transferase. Simin Liu, Peng Zhang, Xinhua Ji et al. · Journal of Biological Chemistry Open access Mar 1992 177
7 Ligand binding and structural perturbations in cytochrome c peroxidase. A crystallographic study. S.L. Edwards, T.L. Poulos · Journal of Biological Chemistry Open access Feb 1990 143
8 Mannosylation of LNP Results in Improved Potency for Self-Amplifying RNA (SAM) Vaccines Roshan Goswami, Despo Chatzikleanthous, Gustavo Lou et al. · ACS Infectious Diseases Open access 10 Jul 2019 116
9 The Surgical Treatment of Tendinitis: Clinical Rationale and Biologic Basis Wayne B. Leadbetter, Pekka A. Mooar, Gregory J. Lane et al. · Clinics in Sports Medicine Oct 1992 114
10 The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70 Céline Boutry et al. · Clinical Infectious Diseases Open access169 authors 20 Jul 2021 94
11 Structural basis for potent antibody-mediated neutralization of human cytomegalovirus Sumana Chandramouli, E. Malito, Tuong-Vi Nguyen et al. · Science Immunology 9 Jun 2017 93
12 Formation, crystal structure, and rearrangement of a cytochrome P-450cam iron-phenyl complex Reetta Raag, Barbara A. Swanson, T.L. Poulos et al. · Biochemistry Sep 1990 71
13 Combined Prebiotic and Microbial Intervention Improves Oral Cholera Vaccination Responses in a Mouse Model of Childhood Undernutrition Blanda Di Luccia, Philip P. Ahern, Nicholas W. Griffin et al. · Cell Host & Microbe Open access 28 Apr 2020 67
14 Cloning, expression, purification, and characterization of biosynthetic threonine deaminase from Escherichia coli. Edward M. Eisenstein · Journal of Biological Chemistry Open access Mar 1991 67
15 Flipping one-shot library instruction: using Canvas and Pecha Kucha for peer teaching Alexander James Carroll, Nedelina Tchangalova, Eileen Harrington · Journal of the Medical Library Association JMLA Open access Apr 2016 54
16 Conjugation of Mannans to Enhance the Potency of Liposome Nanoparticles for the Delivery of RNA Vaccines Roshan Goswami, Derek T. O’Hagan, Roberto Adamo et al. · Pharmaceutics Open access 9 Feb 2021 49
17 Ataluren binds to multiple protein synthesis apparatus sites and competitively inhibits release factor-dependent termination Shijie Huang, A.A. Bhattacharya, Mikel D. Ghelfi et al. · Nature Communications Open access 6 May 2022 48
18 Self-amplifying mRNA-Based Vaccine Technology and Its Mode of Action Giulietta Maruggi, Jeffrey B. Ulmer, Rino Rappuoli et al. · Current topics in microbiology and immunology Book chapter 2021 44
19 Design of a novel vaccine nanotechnology-based delivery system comprising CpGODN-protein conjugate anchored to liposomes Despo Chatzikleanthous, S. Schmidt, Giada Buffi et al. · Journal of Controlled Release Open access 2 Apr 2020 44
20 Educating Healthcare Students: Strategies to Teach Systems Thinking to Prepare New Healthcare Graduates Karen Clark, Ann M. Hoffman · Journal of Professional Nursing 28 Dec 2018 44
21 Characterization of the NISTmAb Reference Material using small-angle scattering and molecular simulation Maria Monica Castellanos, Steven C. Howell, D. Travis Gallagher et al. · Analytical and Bioanalytical Chemistry 9 Feb 2018 33
22 Safety and immunogenicity of a respiratory syncytial virus fusion glycoprotein F subunit vaccine in healthy adults: Results of a phase 1, randomized, observer-blind, controlled, dosage-escalation study Geert G Leroux-Roels, Fien De Boever, Cathy Maes et al. · Vaccine Open access 12 Apr 2019 32
23 Efficacy of the adjuvanted recombinant zoster vaccine (RZV) by sex, geographic region, and geographic ancestry/ethnicity: A post-hoc analysis of the ZOE-50 and ZOE-70 randomized trials David O. Willer et al. · Vaccine Open access 16 Sep 2019 30
24 Changes in Perceptions and Attitudes of Healthcare Profession Students Pre and Post Academic Course Experience of Team-Based 'Care for the Critically Ill' Karen Clark, Heather Brennan Congdon, Kelley R. Macmillan et al. · Journal of Professional Nursing 30 Jan 2015 28
25 Influence of Time-to-Interventions for Emergency Department Critical Care Patients on Hospital Mortality Karen Clark, Loretta Brush Normile · Journal of Emergency Nursing Dec 2006 27
26 The adjuvanted recombinant zoster vaccine co-administered with a tetanus, diphtheria and pertussis vaccine in adults aged ≥50 years: A randomized trial Ana Strezova, Himal Lal, Igwebuike Enweonye et al. · Vaccine Open access 20 Aug 2019 26
27 Opioid use disorder in pregnancy: leveraging provider perceptions to inform comprehensive treatment Doris Titus-Glover, Fadia Tohme Shaya, Christopher J. E. Welsh et al. · BMC Health Services Research Open access 10 Mar 2021 25
28 Modelling the impact of 4CMenB and MenACWY meningococcal combined vaccination strategies including potential 4CMenB cross-protection: An application to England Ekkehard C. Beck, Johan Klint, Stéphanie Garcia et al. · Vaccine Open access 15 Aug 2020 25
29 Arthroscopic Repair of Retracted Large and Massive Rotator Cuff Tears With and Without Augmentation With a Bio‐Inductive Collagen Implant Reveals Substantial and Comparable Clinical Improvement Ting Zhang, Adedapo Ajayi, Michael V. Hajjar et al. · Arthroscopy The Journal of Arthroscopic and Related Surgery 4 Nov 2023 23
30 From recognition to execution — the HCMV Pentamer from receptor binding to fusion triggering E. Malito, Sumana Chandramouli, Andrea Carfı́ · Current Opinion in Virology Review Jun 2018 22
31 Telavancin: A Novel Lipoglycopeptide Antibiotic Lisa Charneski, Priti N. Patel, Donna Sym · Annals of Pharmacotherapy 28 Apr 2009 21
32 The adjuvanted recombinant zoster vaccine co-administered with the 13-valent pneumococcal conjugate vaccine in adults aged ≥50 years: A randomized trial Ji-Young Min, Agnes Mwakingwe-Omari, Megan E Riley et al. · Journal of Infection Open access 25 Dec 2021 20
33 Correlation of protection against varicella in a randomized Phase III varicella-containing vaccine efficacy trial in healthy infants Md. Ahsan Habib, Roman Prymula, Stéphane Carryn et al. · Vaccine Open access 18 Mar 2021 19
34 Growth of a Pharmacy School Through Planning, Cooperation, and Establishment of a Satellite Campus David A. Knapp, David S. Roffman, William Cooper · American Journal of Pharmaceutical Education Open access Sep 2009 18
35 Drosophila Ryanodine Receptors Mediate General Anesthesia by Halothane Shuying Gao, David J. Sandstrom, Harold E. Smith et al. · Anesthesiology Open access 19 Dec 2012 18
36 Managing Troubled Data: Coastal Data Partnerships Smooth Data Integration Stephen S. Hale, Anne Hale Miglarese, Mark P. Bradley et al. Book chapter 2003 18
37 Nonsurgical rhinoplasty Suzel S. Hall, Theda C. Kontis · World Journal of Otorhinolaryngology - Head and Neck Surgery Open access 2 Jul 2023 17
38 Eculizumab in Paroxysmal Nocturnal Haemoglobinuria Lisa Charneski, Priti N. Patel · Drugs 2008 17
39 Safety of the adjuvanted recombinant zoster vaccine in adults aged 50 years or older. A phase IIIB, non-randomized, multinational, open-label study in previous ZOE-50 and ZOE-70 placebo recipients Josephine C Ocran-Appiah et al. · Vaccine Open access130 authors Dec 2020 16
40 The Tactile TON I, a Possible New Performance IQ Test for Blind Adults? Edward M. Duncan, Joseph W. Wiedel, Hugh T. Prickett et al. · Journal of Visual Impairment & Blindness Dec 1989 16
41 Assessing an Interdisciplinary Health Care Model: The Governor's Wellmobile Program Jayshree S. Jani, Carolyn J. Tice, Rebecca Wiseman · Social Work in Health Care May 2012 15
42 Co-administration of the adjuvanted recombinant zoster vaccine with other adult vaccines: An overview Omar Ali, Christophe Dessart, Raunak Parikh · Vaccine Open access 28 Feb 2024 14
43 Systems analysis of human responses to an aluminium hydroxide-adsorbed TLR7 agonist (AS37) adjuvanted vaccine reveals a dose-dependent and specific activation of the interferon-mediated antiviral response Emilio Siena et al. · Vaccine Open access 21 Dec 2022 14
44 Peptidomimetic Polo‐Box‐Targeted Inhibitors that Engage PLK1 in Tumor Cells and Are Selective against the PLK3 Tumor Suppressor Merissa Baxter, Danda P. Chapagai, Sandra N. Craig et al. · ChemMedChem Open access 30 Mar 2020 14
45 Evaluation of a primary course of H9N2 vaccine with or without AS03 adjuvant in adults: A phase I/II randomized trial Anuradha Madan, Harry Collins, Eric A. Sheldon et al. · Vaccine Open access 15 Jul 2017 14
46 Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in healthy adults: A phase I/II, observer-blind, randomized, controlled trial Anuradha Madan, Murdo Ferguson, Eric A. Sheldon et al. · Vaccine Open access 8 Feb 2017 14
47 B-Cell Gene Therapy for Tolerance Induction: Host but Not Donor B-Cell Derived IL-10 is Necessary for Tolerance Yan Su, Ai-Hong Zhang, Nancy Noben-Trauth et al. · Frontiers in Microbiology Open access 2011 14
48 Effective Multivalent Oriented Presentation of Meningococcal NadA Antigen Trimers by Self-Assembling Ferritin Nanoparticles Daniele Veggi, Lucia Dello Iacono, E. Malito et al. · International Journal of Molecular Sciences Open access 24 Mar 2023 13
49 Differences in the oral health status in hospitalised stroke patients according to swallowing function: A cross‐sectional study Fang Tian, Juan Li, Bei Wu et al. · Journal of Clinical Nursing Open access 6 Mar 2022 13
50 A prospective, multicentre, cohort study to assess the incidence of dengue illness in households from selected communities in Brazil (2014–2018) Daniele Fernandes de Aguiar, Eliana Nogueira Castro de Barros, Guilherme S. Ribeiro et al. · International Journal of Infectious Diseases Open access 21 Apr 2021 13

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.